Registered entities
Pdx Pharmaceuticals, Inc.
Reg. No. 843790146United States
Innovation
6 patent families (3 granted) — focus: Human necessities; filing pace steady. Cited 1,047 times.
| Year | Filings |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 1 |
Social engagement
Social engagement: 1.4K social following, 7 posts in the last 12 months — below the industry typical range.
Investor mix
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Accelerator & incubator | 1 | 50% |
| Other / undisclosed | 1 | 50% |
Recent activity
30 Jun 2026
Milestone
regulatory
23 Jun 2026
Product launch
AIRISE-02
28 Apr 2026
Milestone
regulatory